← FDA DRUG APPROVALS

FDA ANDA · ANDA065220

NEOMYCIN SULFATE

Sponsor: SOLARIS PHARMA CORP

APPLICATION
ANDA065220
TYPE
ANDA
ORIGINAL APPROVAL
2006-07-28
LATEST ACTION
2023-02-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

NEOMYCIN SULFATEPrescription
NEOMYCIN SULFATE 500MG · TABLET · ORAL

Approval history

2023-02-10Labeling · Supplement 4 · standardAP
2006-07-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →